Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca2+ release, and activation of protein kinase C

Frontiers in Molecular Neuroscience

Volumn 7, Issue AUG, 2014, Pages

  Pandey, Kailash N ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

cAMP; cGMP; Inositol triphosphate; Membrane guanylyl cyclases; Natriuretic peptide receptors; Natriuretic peptides

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANGIOTENSIN II; ATRIAL NATRIURETIC FACTOR; BETA ADRENERGIC RECEPTOR; BRAIN NATRIURETIC PEPTIDE; CYCLIC AMP; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIN 1; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANYLATE CYCLASE; INOSITOL TRISPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE RECEPTOR C; NATRIURETIC PEPTIDE TYPE C; PHOSPHATIDYLINOSITIDE; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE C; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA1; URODILATIN;

APOPTOSIS; BINDING SITE; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONGESTIVE HEART FAILURE; CROSS LINKING; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE; GENE DISRUPTION; GENE DUPLICATION; GENE TARGETING; GENETIC TRANSCRIPTION; GLOMERULUS FILTRATION RATE; HEART ATRIUM; HUMAN; INTERNALIZATION; KIDNEY PLASMA FLOW; MOLECULAR CLONING; NONHUMAN; NPR1 GENE; PHENOTYPE; PHOTOAFFINITY LABELING; PROTEIN ANALYSIS; REVIEW; SIGNAL TRANSDUCTION; URINE FLOW RATE;

EID: 84927710055     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2014.00075     Document Type: Review

References (205)

1. Airhart, N., Yang, Y. F., Roberts, C. T. Jr., and Silberbach, M. (2003). Atrial natriuretic peptide induces natriuretic peptide receptor-cGMP-dependent protein kinase interaction. J. Biol. Chem. 278, 38693-38698. doi: 10.1074/jbc.M304098200
2. Anand-Srivastava, M. B. (2000). Down-regulation of atrial natriuretic peptide ANP-C receptor is associated with alteration in G-protein expression in A10 smooth muscle cells. Biochemistry 39, 6503-6513. doi: 10.1021/bi992660q
3. Anand-Srivastava, M. B., and Trachte, G. J. (1993). Atrial natriuretic factor receptors and signal transduction mechanisms. Pharmacol. Rev. 45, 455-497. doi: 10.1007/s11010-009-0335-7
4. Anderson, R. A., Feathergill, K. A., De Jonge, C., Mack, S. R., and Zaneveld, L. J. D. (1992). Facilitative effect of pulsed addition of dibutyryl-cAMP on the acrosome reaction of noncapacitated human spermotazoa. J. Androl. 13, 398-408.
5. Anderson, R. A., Feathergill, K. A., Drisdel, R. C., Rawlins, R. G., Mack, S. R., and Zaneveld, L. J. D. (1994). Atrial natriuretic peptide (ANP) as a stimulus of the human acrosome reaction and a component of ovarian follicular fluid: correlation of follicular ANP content with in vitro fertilization outcome. J. Androl. 15, 61-70. doi: 10.1002/j.1939-4640.1994.tb01685.x
6. Anwaruddin, S., Lloyd-Jones, D. M., Baggish, A., Chen, A., Krauser, D., Tung, R., et al. (2006). Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic petpide measurement: results from the proBNP investigation of dyspnea in the emergency Department (PRIDE) study. J. Am. Coll. Cardiol. 47, 91-97. doi: 10.1016/j.jacc.2005.08.051
7. Arise, K. K., and Pandey, K. N. (2006). Inhibition and down-regulation of gene transcription and guanylyl cyclase activity of NPRA by angiotensin II involving protein kinase C. Biochem. Biophys. Res. Commun. 349, 131-135. doi: 10.1016/j.bbrc.2006.08.003
8. Ballerman, B. J., Marala, R. B., and Sharma, R. K. (1988). Characterization and regulation by protein kinase C of renal glomerular atrial natriuretic peptide receptor-coupled guanylate cyclase. Biochem. Biophys. Res. Commun. 157, 755-761. doi: 10.1016/S0006-291X(88)80314-0
9. Berl, T., Mansour, J., and Teitelbaum, I. (1991). ANP stimulates phospholipase C in cultured RIMCT cells: roles of protein kinases and G proteins. Am. J. Physiol. 260, F590-F595.
10. Berridge, M. J., and Irvine, R. F. (1989). Inositol phosphates adn cel signaling. Nature 341, 197-205. doi: 10.1038/341197a0
11. Bornfildt, K. E., and Krebs, E. G. (1999). Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. Cell. Signal. 11, 465-477. doi: 10.1016/S0898-6568(99)00020-0
12. Bovy, P. R. (1990). Structure activity in the atrial natriuretic peptide (ANP) family. Med. Res. Rev. 10, 115-142. doi: 10.1002/med.2610100105
13. Breitbart, H., Lax, J., Rotem, R., and Naor, J. (1992). Role of protein kinase C in the acrosome reaction of mammalian spermatozoa. Biochem. J. 281, 473-476.
14. Brenner, B. M., Ballermann, B. J., Gunning, M. E., and Zeidel, M. L. (1990). Diverse biological actions of atrial natriuretic peptide. Physiol. Rev. 70, 665-699.
15. Calderone, A., Thaik, C. M., Takahashi, N., Chang, D. L. F., and Colucci, W. S. (1998). Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J. Clin. Invest. 101, 812-818. doi: 10.1172/JCI119883
16. Cameron, V. A., Aitken, G. D., Ellmers, L. J., Kennedy, M. A., and Espiner, E. A. (1996). The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology 137, 817-824.
17. Cao, L., Chen, S. C., Humphreys, M. H., and Gardner, D. G. (1998). Ligand-dependent regulation of NPR-A gene expression in inner medullary collecting duct cells. Am. J. Physiol. 275, F119-F125.
18. Cao, L., Wu, J., and Gardner, D. G. (1995). Atrial natriuretic peptide suppresses the transcription of its guanylyl cyclase-linked receptor. J. Biol. Chem. 270, 24891-24897. doi: 10.1074/jbc.270.42.24891
19. Chang, C.-H., Kohse, K. P., Chang, B., Hirata, M., Jiang, B., Douglas, J. E., et al. (1990). Characterization of ATP-stimulated guanylyl cyclase activation in rat lung membranes. Biochim. Biophys. Acta 1052, 159-165. doi: 10.1016/0167-4889(90)90071-K
20. Chen, H. H., and Burnett, J. C. Jr. (1998). C-type natriuretic peptide: the endothelial component of the natriuretic peptide system. J. Cardiovasc. Pharmacol. 32(Suppl. 3), S22-S28. doi: 10.1038/jcbfm.2013.234
21. Chen, Y. O., and Gardner, D. G. (2003). Endothelin inhibits NPR-A and stimulates eNOS gene expression in rat IMCD cells. Hypertension 41 675-681. doi: 10.1161/01.HYP.0000047204.72286.34
22. Chinkers, M., Garbers, D. L., Chang, M. S., Lowe, D. G., Chin, H. M., Goeddel, D. V., et al. (1989). A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature 338, 78-83. doi: 10.1038/338078a0
23. Chinkers, M., Singh, S., and Garbers, D. L. (1991). Adenine nucleotides are required for activation of rat atrial natriuretic peptide receptor/guanylyl cyclase expressed in a baculovirus system. J. Biol. Chem. 266, 4088-4093.
24. Chrisman, T. D., and Garbers, D. L. (1999). Reciprocal antagonism coordinates C-type natriuretic peptide and mitogen-signaling pathways in fibroblasts. J. Biol. Chem. 274, 4293-4299. doi: 10.1074/jbc.274.7.4293
25. Cohen, D., Koh, G. Y., Nikonova, L. N., Porter, J. G., and Maack, T. (1996). Molecular determinants of the clearance function of type-C receptor of natriuretic peptides. J. Biol. Chem. 271, 9863-9869. doi: 10.1074/jbc.271.16.9863
26. Cornwell, T. L., and Lincoln, T. M. (1989). Regulation of intracellular Ca2+ levels in cultured vascular smooth muscle cells. Reduction of Ca2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J. Biol. Chem. 264, 1146-1155.
27. Czucz, J., Cervenak, L., Forhecz, Z., Gombos, T., Pozsonyi, Z., Kunde, J., et al. (2011). Serum soluble E-selectin and NT-proBNP levels additively predict mortality in diabetic patients with chronic heart failure. Clin. Res. Cardiol. 100, 587-594. doi: 10.1007/s00392-011-0283-6
28. Das, S., Periyasamy, R., and Pandey, K. N. (2012). Activation of IKK/NF-kappaB provokes renal inflammatory responses in guanylyl cyclase/natriuretic peptide receptor-A gene-knockout mice. Physiol. Genomics 44, 430-442. doi: 10.1152/physiolgenomics.00147.2011
29. de Bold, A. J. (1985). Atrial natriuretic factor: a hormone produced by the heart. Science 230, 767-770. doi: 10.1126/science.2932797
30. de Bold, A. J., Borenstein, H. B., Veress, A. T., and Sonnenberg, H. (1981). A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 28, 89-94. doi: 10.1016/0024-3205(81)90370-2
31. Dekker, L. V., and Parker, P. J. (1994). Protein kinase C: a question of specficicit. Trends Biochem. Sci. 19, 73-77. doi: 10.1016/0968-0004(94)90038-8
32. Del Ry, S. (2013). C-type natriuretic peptide: a new cardiac mediator. Peptides 40, 93-98. doi: 10.1016/j.peptides.2012.12.010
33. Dey, N. B., Boerth, N. J., Murphy-Ullrich, J. E., Chang, P. L., Prince, C. W., and Lincoln, T. M. (1998). Cyclic GMP-dependent protein kinase inhibits osteopontin and thrombospondin production in rat aortic smooth muscle cells. Circ. Res. 82 139-146. doi: 10.1161/01.RES.82.2.139
34. Doust, J. A., Pietrzak, E., Dobson, A., and Glasziou, P. (2005). How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330, 625. doi: 10.1136/bmj.330.7492.625
35. Drewett, J. G., and Garbers, D. L. (1994). The family of guanylyl cyclase receptors and their ligands. Endocr. Rev. 15, 135-162. doi: 10.1210/edrv-15-2-135
36. Duda, T., Goraczniak, R. M., and Sharma, R. K. (1991). Site-directed mutational analysis of a membrane guanylate cyclase cDNA reveals the atrial natriuretic factor signaling site. Proc. Natl. Acad. Sci. U. S. A. 88, 7882-7886. doi: 10.1073/pnas.88.17.7882
37. Duda, T., Goraczniak, R. M., and Sharma, R. K. (1993). Core sequence of ATP regulatory module in receptor guanylate cyclases. FEBS Lett. 315, 143-148. doi: 10.1016/0014-5793(93)81151-O
38. Duda, T., and Sharma, R. K. (1990). Regulation of guanylate cyclase activity by atrial natriuretic factor and protein kinase C. Mol. Cell. Biochem. 93, 179-184. doi: 10.1007/BF00226190
39. Emori, T., Hirata, Y., Imai, T., Eguchi, S., Kanno, K., and Marumos, F. (1993). Cellular mechanism of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells. Endocrinology 133, 2474-2480.
40. Exton, J. H. (1990). Signaling through phosphatidylcholine breakdow. J. Biol. Chem. 265, 1-4.
41. Felker, G. M., Petersen, J. W., and Mark, D. W. (2006). Natriuretic peptides in the diagnosis and management of heart failure. CMAJ 175, 611-617. doi: 10.1503/cmaj.060236
42. Fenrick, R., Bouchard, N., Mcnicoll, N., and De Lean, A. (1997). Glycosylation of asparagines 24 of the natriuretic peptide receptor-B is crucial for the formation of a competent ligand binding domain. Mol. Cell. Biochem. 173, 25-32. doi: 10.1023/A:1006855522272
43. Freestone, B., Gustafsson, F., Chong, A. Y., Corell, P., Kistorp, C., Hildebrandt, P., et al. (2008). Influence of atrial fibrillation on plasma von willebrand factor, soluble E-selectin, and N-terminal pro B-type natriuretic peptide levels in systolic heart failure. Chest 133, 1203-1208. doi: 10.1378/chest.07-2557
44. Fujio, N., Gossard, F., Bayard, F., and Tremblay, J. (1994). Regulation of natriuretic peptide receptor A and B expression by transforming growth factor-beta 1 in cultured aortic smooth muscle cells. Hypertension 23, 908-913. doi: 10.1161/01.HYP.23.6.908
45. Fuller, F., Porter, J. G., Arfsten, A. E., Miller, J., Schilling, J. W., Scarborough, R. M., et al. (1988). Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones. J. Biol. Chem. 263, 9395-9401.
46. Ganem, F., Serrano, C. V. Jr., Fernandes, J. L., Blotta, M. H., Souza, J. A., and Nicolau, J. C. (2011). Preoperative B-type natriuretic peptide, and not the inflammation status, predicts an adverse outcome for patients undergoing heart surgery. Interact. Cardiovasc. Thorac. Surg. 12, 778-783. doi: 10.1510/icvts.2010.255257
47. Garbers, D. L. (1992). Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands. Cell 71, 1-4. doi: 10.1016/0092-8674(92)90258-E
48. Gardner, D. G., Deschepper, C. F., Ganong, W. F., Hane, S., Fiddes, J., Baxter, J. D., et al. (1986). Extra-atrial expression of the gene for atrial natriuretic factor. Proc. Natl. Acad. Sci. U. S. A. 83, 6697-6701. doi: 10.1073/pnas.83.18.6697
49. Garg, R., and Pandey, K. N. (2003). Angiotensin II-mediated negative regulation of Npr1 promoter activity and gene transcription. Hypertension 41, 730-736. doi: 10.1161/01.HYP.0000051890.68573.94
50. Gopi, V., Parthasarathy, A., Umadevi, S., and Vellaichamy, E. (2013). Angiotensin-II down-regulates cardiac natriuretic peptide receptor-A mediated anti-hypertrophic signaling in experimental rat hearts. Indian J. Exp. Biol. 51, 48-55.
51. Goraczniak, R. M., Duda, T., and Sharma, R. K. (1992). A structural motif that defines the ATP-regulatory module of guanylate cyclase in atrial natriuretic factor signalling. Biochem. J. 282(Pt 2), 533-537.
52. Hama, N., Itoh, H., Shirakami, G., Suga, S., Komatsu, Y., Yoshimasa, T., et al. (1994). Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients. Biochem. Biophys. Res. Commun. 198, 1177-1182. doi: 10.1006/bbrc.1994.1166
53. Hamet, P., Tremblay, J., Pang, S. C., Garcia, R., Thibault, G., Gutkowska, J., et al. (1984). Effect of native and synthetic atrial natriuretic factor on cyclic GMP. Biochem. Biophys. Res. Commun. 123, 515-527. doi: 10.1016/0006-291X(84)90260-2
54. Hassid, A. (1986). Atriopeptin II decreases cytosolic free Ca2+ in cultured vascular smooth muscle cells. Am. J. Physiol. 251, C681-C686.
55. Heim, J. M., Singh, S., and Gerzer, R. (1996). Effect of glycosylation on cloned ANF-sensitive guanylyl cyclase. Life Sci. 59, L61-L68. doi: 10.1016/0024-3205(96)00306-2
56. Hesegawa, M., Hidaka, Y., Wada, A., Hirayama, T., and Shimonishi, Y. (1999). The relevance of N-linked glycosylation to the binding of a ligand to guanylate cyclase C. Eur. J. Biochem. 263, 338-346. doi: 10.1046/j.1432-1327.1999.00488.x
57. Hirata, M., Chang, C. M., and Murad, F. (1989). Stimulatory effect of atrial natriuretic factor on phosphoinositide hydrolysis in cultured bovine aortic smooth muscle cells. Biochim. Biophys. Acta 1010, 346-351. doi: 10.1016/0167-4889(89)90060-8
58. Hirata, Y., Hirose, S., Takada, S., Takagi, Y., and Matsubara, H. (1987). Down-regulation of atrial natriuretic peptide receptor and cyclic GMP response in cultured rat vascular smooth muscle cells. Eur. J. Pharmacol. 135, 439-442. doi: 10.1016/0014-2999(87)90697-2
59. Hirata, Y., Takata, S., Tomita, M., and Takaichi, S. (1985). Binding, internalization, and degradation of atrial natriuretic peptide in cultured vascular smooth muscle cells of rat. Biochem. Biophys. Res. Commun. 132, 976-984. doi: 10.1016/0006-291X(85)91903-5
60. Holtwick, R., Baba, H. A., Ehler, E., Risse-Vob, M. D., Gehrmann, J., Pierkes, M., et al. (2002). Left but not right cardiac hypertrophy in atrial natriuretic peptide receptor-deficient mice is prevented by angiotensin type 1 receptor antagonist losartan. J. Cardiovasc. Pharmacol. 40, 725-734. doi: 10.1097/00005344-200211000-00010
61. Horio, T., Nishikimi, T., Yoshihara, F., Matsuo, H., Takishita, S., and Kangawa, K. (2000). Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 35, 19-24. doi: 10.1161/01.HYP.35.1.19
62. Hug, H., and Sarre, T. F. (1993). Protein kinase C isoenzymes: divergence in signal transduction. Biochem. J. 291, 329-343.
63. Hughes, R. J., Struthers, R. S., Fong, A. M., and Insel, P. A. (1987). Regulation of the atrial natriuretic peptide receptor on a smooth muscle cell. Am. J. Physiol. 253, C809-C816.
64. Hugnir, R. I., and Greengard, P. (1990). Regulation of neurotransmitter receptor desensitization by protein phosphorylation. Neuron 5, 555-567. doi: 10.1016/0896-6273(90)90211-W
65. Hum, D., Besnard, S., Sanchez, R., Devost, D., Gossard, F., Hamet, P., et al. (2004). Characterization of a cGMP-response element in the guanylyl cyclase/natriuretic peptide receptor A gene promoter. Hypertension 43, 1270-1278. doi: 10.1161/01.HYP.0000126920.93207.53
66. Huo, X., Abe, T., and Misono, K. S. (1999). Ligand binding-dependent limited proteolysis of the atrial natriuretic peptide juxtamembrane hinge structure essential for transmembrane signal transduction. Biochemistry 38, 16941-16951. doi: 10.1021/bi9919448
67. Hutchinson, H. G., Trinadade, P. T., Cunanan, D. B., Wu, C. F., and Pratt, R. E. (1997). Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells. Cardiovasc. Res. 35 158-167. doi: 10.1016/S0008-6363(97)00086-2
68. Igaki, T., Itoh, H., Suga, S., Hama, N., Ogawa, Y., Komatsu, Y., et al. (1996). C-type natriuretic peptide in chronic renal failure and its action in humans. Kidney Int. Suppl. 55, S144-S147.
69. Inagami, T. (1989). Atrial natriuretic factor. J. Biol. Chem. 264, 3043-3046.
70. Jaffe, A. S., Babuin, L., and Apple, F. S. (2006). Biomarkers in acute cardiac disease: the present and the future. J. Am. Coll. Cardiol. 48, 1-11. doi: 10.1016/j.jacc.2006.02.056
71. John, S. W., Krege, J. H., Oliver, P. M., Hagaman, J. R., Hodgin, J. B., Pang, S. C., et al. (1995). Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267, 679-681. doi: 10.1126/science.7839143
72. Khan, I. A., Fink, J., Nass, C., Chen, H., Christenson, R., and Defilippi, C. R. (2006). N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients. Am. J. Cardiol. 97, 1530-1534. doi: 10.1016/j.amjcard.2005.11.090
73. Khurana, M. L., and Pandey, K. N. (1993). Receptor-mediated stimulatory effect of atrial natriuretic factor, brain natriuretic peptide, and C-type natriuretic peptide on testosterone production in purified mouse Leydig cells: activation of cholesterol side-chain cleavage enzyme. Endocrinology 133, 2141-2149.
74. Khurana, M. L., and Pandey, K. N. (1995). Catalytic activation of guanylate cyclase/atrial natriuretic factor receptor by combined effects of ANF and GTP gamma S in plasma membranes of Leydig tumor cells: involvement of G-proteins. Arch. Biochem. Biophys. 316, 392-398. doi: 10.1006/abbi.1995.1052
75. Khurana, M. L., and Pandey, K. N. (1996). Atrial natriuretic peptide inhibits the phosphoinositide hydrolysis in murine Leydig tumor cells. Mol. Cell. Biochem. 158, 97-105. doi: 10.1007/BF00225834
76. Kiefer, M. C., Brauer, M. J., Powers, V. C., Wu, J. J., Umansky, S. R., Tomel, L. D., et al. (1995). Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374, 736-739. doi: 10.1038/374736a0
77. Kim, H. S., Lu, G., John, S. W. M., Maeda, N., and Smithies, O. (2002). Molecular phenotyping for analyzing subtle genetic effects in mice application to an angiotensinogen gene titration. Proc. Natl. Acad. Sci. U. S. A. 99, 4602-4607. doi: 10.1073/pnas.072083799
78. Kishimoto, I., Dubois, S. K., and Garbers, D. L. (1996). The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: acute handling of sodium and water in response to volume expansion. Proc. Natl. Acad. Sci. U. S. A. 93, 6215-6219. doi: 10.1073/pnas.93.12.6215
79. Kishimoto, I., Tokudome, T., Nakao, K., and Kangawa, K. (2011). Natriuretic peptide system: an overview of studies using genetically engineered animal models. FEBS J. 278, 1830-1841. doi: 10.1111/j.1742-4658.2011.08116.x
80. Knowles, J. W., Esposito, G., Mao, L., Hagaman, J. R., Fox, J. E., Smithies, O., et al. (2001). Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice. J. Clin. Invest. 107, 975-984. doi: 10.1172/JCI11273
81. Kojima, M., Minamino, N., Kangawa, K., and Matsuo, H. (1989). Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide. Biochem. Biophys. Res. Commun. 159, 1420-1426. doi: 10.1016/0006-291X(89)92268-7
82. Koller, K. J., Lipari, M. T., and Goeddel, D. V. (1993). Proper glycosylation and phosphorylation of the type A natriuretic peptide receptor are required for hormone-stimulated guanylyl cyclase activity. J. Biol. Chem. 268, 5997-6003.
83. Koller, K. J., Lowe, D. G., Bennett, G. L., Minamino, N., Kangawa, K., Matsuo, H., et al. (1991). Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide (CNP). Science 252, 120-123. doi: 10.1126/science.1672777
84. Komalavilas, P., Shah, P. K., Jo, H., and Lincoln, T. M. (1999). Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells. J. Biol. Chem. 274, 34301-34309. doi: 10.1074/jbc.274.48.34301
85. Komatsu, Y., Endo, Y., and Suzaki, S. (1990). Changes in protein phoshorylation during acrosome reaction of mouse sperm. Yakugaku Zasshi 110, 325-331.
86. Komuro, I., Katoh, Y., Kaida, T., Shibazaki, Y., Kurabayashi, M., Hoh, E., et al. (1991). Mechanical loading stimulates cell hypertrophy and specific gene expression in cultured rat cardiac myocytes. Possible role of protein kinase C activation. J. Biol. Chem. 266, 1265-1268.
87. Kozopas, K. M., Yang, T., Buchan, H. L., Zhou, P., and Craig, R. W. (1993). MCLI, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc. Natl. Acad. Sci. U. S. A. 90, 3516-3520. doi: 10.1073/pnas.90.8.3516
88. Kumar, P., Garg, R., Bolden, G., and Pandey, K. N. (2010). Interactive roles of Ets-1, Sp1, and acetylated histones in the retinoic acid-dependent activation of guanylyl cyclase/atrial natriuretic peptide receptor-A gene transcription. J. Biol. Chem. 285, 37521-37530. doi: 10.1074/jbc.M110.132795
89. Kumar, P., Periyasamy, R., Das, S., Neerukonda, S., Mani, I., and Pandey, K. N. (2014a). All-trans retinoic acid and sodium butyrate enhance natriuretic peptide receptor a gene transcription: role of histone modification. Mol. Pharmacol. 85, 946-957. doi: 10.1124/mol.114.092221
90. Kumar, P., Tripathi, S., and Pandey, K. N. (2014b). Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-A gene: interactive roles of modified histones, HATS, p300, and Sp1. J. Biol. Chem. 289, 6991-7002. doi: 10.1074/jbc.M113.511444
91. Kumar, R., Cartledge, W. A., Lincoln, T. M., and Pandey, K. N. (1997). Expression of guanylyl cyclase-A/atrial natriuretic peptide receptor blocks the activation of protein kinase C in vascular smooth muscle cells. Role of cGMP and cGMP-dependent protein kinase. Hypertension 29, 414-421. doi: 10.1161/01.HYP.29.1.414
92. Kuno, T., Andresen, J. W., Kamisaki, Y., Waldman, S. A., Chang, L. Y., Saheki, S., et al. (1986). Co-purification of an atrial natriuretic factor receptor and particulate guanylate cyclase from rat lung. J. Biol. Chem. 261, 5817-5823.
93. Kurose, H., Inagami, T., and Ui, M. (1987). Participation of adenosine 5'-triphosphate in the activation of membrane-bound guanylate cyclase by the atrial natriuretic factor. FEBS Lett. 219, 375-379. doi: 10.1016/0014-5793(87)80256-9
94. Labrecque, J., Mcnicoll, N., Marquis, M., and De Lean, A. (1999). A disulfide-bridged mutant of natriuretic peptide receptor-A displays constitutive activity. Role of receptor dimerization in signal transduction. J. Biol. Chem. 274, 9752-9759. doi: 10.1074/jbc.274.14.9752
95. Larose, L., Mcnicoll, N., Ong, H., and De Lean, A. (1991). Allosteric modulation by ATP of the bovine adrenal natriuretic factor R1 receptor functions. Biochemistry 30, 8990-8995. doi: 10.1021/bi00101a012
96. Larose, L., Rondeau, J. J., Ong, H., and De Lean, A. (1992). Phosphorylation of atrial natriuretic factor R1 receptor by serine/threonine protein kinases: evidences for receptor regulation. Mol. Cell. Biochem. 115, 203-211. doi: 10.1007/BF00230332
97. Lefkowitz, R. J., Pitcher, J., Krueger, K., and Daaka, Y. (1998). Mechanisms of β-adrenergic receptor desensitization and resensitization. Adv. Pharmacol. 42, 416-420. doi: 10.1016/S1054-3589(08)60777-2
98. Leitman, D. C., Andresen, J. W., Catalano, R. M., Waldman, S. A., Tuan, J. J., and Murad, F. (1988). Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells. J. Biol. Chem. 263, 3720-3728.
99. Levin, E. R., Gardner, D. G., and Samson, W. K. (1998). Natriuretic peptides. N. Engl. J. Med. 339, 321-328. doi: 10.1056/NEJM199807303390507
100. Lincoln, T. M., Komalavilas, P., and Cornwell, T. L. (1994). Pleiotropic regulation of vascular smooth muscle tone by cyclic GMP-dependent protein kinase. Hypertension 243, 383-385.
101. Lisy, O., Jougasaki, M., Heublein, D. M., Schirger, J. A., Chen, H. H., Wennberg, P. W., et al. (1999). Renal actions of synthetic Dendroaspis natriuretic peptide. Kidney Int. 56, 502-508. doi: 10.1046/j.1523-1755.1999.00573.x
102. Lopez, M. J., Wong, S. K.-F., Kishimoto, I., Dubois, S., Mach, V., Friesen, J., et al. (1995). Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378, 65-68. doi: 10.1038/378065a0
103. Louis, J. C., Magal, E., and Yavin, E. (1988). Protein kinase C alterations in the fetal rat brain after global ischemia. J. Biol. Chem. 263, 19282-19285.
104. Lowe, D. G., and Fendly, B. M. (1992). Human natriuretic peptide receptor-A guanylyl cyclase. Hormone cross-linking and antibody reactivity distinguish receptor glycoforms. J. Biol. Chem. 267, 21691-21697.
105. Lucas, K. A., Pitari, G. M., Kazerounian, S., Ruiz-Stewart, I., Park, J., Schulz, S., et al. (2000). Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev. 52, 375-414.
106. Maack, T., Suzuki, M., Almeida, F. A., Nussenzveig, D., Scarborough, R. M., Mcenroe, G. A., et al. (1987). Physiological role of silent receptors of atrial natriuretic factor. Science 238, 675-678. doi: 10.1126/science.2823385
107. Maki, M., Takayanagi, R., Misono, K. S., Pandey, K. N., Tibbetts, C., and Inagami, T. (1984). Structure of rat atrial natriuretic factor precursor deduced from cDNA sequence. Nature 309, 722-724. doi: 10.1038/309722a0
108. Marala, R., Duda, T., Goraczniak, R. M., and Sharma, R. K. (1992). Genetically tailored atrial natriuretic factor-dependent guanylate cyclase. Immunological and functional identity with 180 kDa membrane guanylate cyclase and ATP signaling site. FEBS Lett. 296, 254-258. doi: 10.1016/0014-5793(92)80298-U
109. Masciotra, S., Picard, S., and Deschepper, C. F. (1999). Cosegregation analysis in genetic crosses suggests a protective role for atrial natriuretic factor against ventricular hypertrophy. Circ. Res. 84, 1453-1458. doi: 10.1161/01.RES.84.12.1453
110. Matsukawa, N., Grzesik, W. J., Takahashi, N., Pandey, K. N., Pang, S., Yamauchi, M., et al. (1999). The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc. Natl. Acad. Sci. U. S. A. 96, 7403-7408. doi: 10.1073/pnas.96.13.7403
111. McCullough, P. A., Duc, P., Omland, T., Mccord, J., Nowak, R. M., Hollander, J. E., et al. (2003). B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the breathing not properly multinational study. Am. J. Kidney Dis. 41, 571-579. doi: 10.1053/ajkd.2003.50118
112. Melo, L. G., Veress, A. T., Ackermann, U., Steinhelper, M. E., Pang, S. C., Tse, Y., et al. (1999). Chronic regulation of arterial blood pressure in ANP transgenic and knockout mice: role of cardiovascular sympathetic tone. Cardiovasc. Res. 43, 437-444. doi: 10.1016/S0008-6363(99)00104-2
113. Meloche, S., Mcnicoll, N., Liu, B., Ong, H., and De Lean, A. (1988). Atrial natriuretic factor R1 receptor from bovine adrenal zona glomerulosa: purification, characterization, and modulation by amiloride. Biochemistry 27, 8151-8158. doi: 10.1021/bi00421a025
114. Meloche, S., Ong, H., Cantin, M., and De Lean, A. (1986). Affinity cross-linking of atrial natriuretic factor to its receptor in bovine adrenal zona glomerulosa. J. Biol. Chem. 261, 1525-1528.
115. Meyer, M., Richter, R., Brunkhorst, R., Wrenger, E., Schulz-Knappe, P., Kist, A., et al. (1996). Urodilatin is involved in sodium homeostasis and exerts sodium-state-dependent natriuretic and diuretic effects. Am. J. Physiol. 271, F489-F497.
116. Misono, K. S., Fukumi, H., Grammer, R. T., and Inagami, T. (1984). Rat atrial natriuretic factor: complete amino acid sequence and disulfide linkage essential for biological activity. Biochem. Biophys. Res. Commun. 119, 524-529. doi: 10.1016/S0006-291X(84)80279-X
117. Misono, K. S., Grammer, R. T., Rigby, J. W., and Inagami, T. (1985). Photoaffinity labeling of atrial natriuretic factor receptor in bovine and rat adrenal cortical membranes. Biochem. Biophys. Res. Commun. 130, 994-1001. doi: 10.1016/0006-291X(85)91713-9
118. Miyagi, M., Zhang, X., and Misono, K. S. (2000). Glycosylation sites in the atrial natriuretic peptide receptor oligosaccharide structures are not required for hormone binding. Eur. J. Biochem. 267, 5758-5768. doi: 10.1046/j.1432-1327.2000.01647.x
119. Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y., et al. (1991). Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J. Clin. Invest. 87, 1402-1412. doi: 10.1172/JCI115146
120. Murthy, K. K., Thibault, G., and Cantin, M. (1989). Binding and intracellular degradation of atrial natriuretic factor by cultured vascular smooth muscle cells. Mol. Cell. Endocrinol. 67, 195-206. doi: 10.1016/0303-7207(89)90210-4
121. Napier, M., Arcuri, K., and Vandlen, R. (1986). Binding and internalization of atrial natriuretic factor by high-affinity receptors in A10 smooth muscle cells. Arch. Biochem. Biophys. 248, 516-522. doi: 10.1016/0003-9861(86)90504-7
122. Neuser, D., and Bellermann, P. (1986). Receptor binding, cGMP stimulation and receptor desensitization by atrial natriuretic peptides in cultured A10 vascular smooth muscle cells. FEBS Lett. 209, 347-351. doi: 10.1016/0014-5793(86)81140-1
123. Nussenzveig, D. R., Lewicki, J. A., and Maack, T. (1990). Cellular mechanisms of the clearance function of type-C receptors of atrial natriuretic factor. J. Biol. Chem. 265, 20952-20958.
124. Ogawa, Y., Nakao, K., Nakagawa, O., Komatsu, Y., Hosoda, K., Suga, S., et al. (1992). Human C-type natriuretic peptide. Characterization of the gene and peptide. Hypertension 19, 809-813. doi: 10.1161/01.HYP.19.6.809
125. Oliver, P. M., Fox, J. E., Kim, R., Rockman, H. A., Kim, H. S., Reddick, R. L., et al. (1997). Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc. Natl. Acad. Sci. U. S. A. 94, 14730-14735. doi: 10.1073/pnas.94.26.14730
126. Oliver, P. M., John, S. W., Purdy, K. E., Kim, R., Maeda, N., Goy, M. F., et al. (1998). Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner. Proc. Natl. Acad. Sci. U. S. A. 95 2547-2551. doi: 10.1073/pnas.95.5.2547
127. Omland, T., Aakvaag, A., Bonarjee, V. V., Caidahl, K., Lie, R. T., Nilsen, D. W., et al. (1996). Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93, 1963-1969. doi: 10.1161/01.CIR.93.11.1963
128. Pandey, K., Kumar, R., Li, M., and Nguyen, H. T. (2000a). Functional domains and expression of truncated atrial natriuretic peptide receptor-A: the carboxyl-terminal regions direct the receptor internalization and sequestration in COS-7 cells. Mol. Pharmacol. 57, 259-267.
129. Pandey, K. N., Nguyen, H. T., Li, M., and Boyle, J. W. (2000b). Natriuretic peptide receptor-A negatively regulates mitogen-activated protein kinase and proliferation of mesangial cells: role of cGMP-dependent protein kinase. Biochem. Biophys. Res. Commun. 271, 374-379. doi: 10.1006/bbrc.2000.2627
130. Pandey, K. N. (1989). Stimulation of protein phosphorylation by atrial natriuretic factor in plasma membranes of bovine adrenal cortical cells. Biochem. Biophys. Res. Commun. 163, 988-994. doi: 10.1016/0006-291X(89)92319-X
131. Pandey, K. N. (1992). Kinetic analysis of internalization, recycling and redistribution of atrial natriuretic factor-receptor complex in cultured vascular smooth-muscle cells. Ligand-dependent receptor down-regulation. Biochem. J. 288, 55-61.
132. Pandey, K. N. (1993). Stoichiometric analysis of internalization, recycling, and redistribution of photoaffinity-labeled guanylate cyclase/atrial natriuretic factor receptors in cultured murine Leydig tumor cells. J. Biol. Chem. 268, 4382-4390.
133. Pandey, K. N. (1994a). Atrial natriuretic factor inhibits autophosphorylation of protein kinase C and A 240-kDa protein in plasma membranes of bovine adrenal glomerulosa cells: involvement of cGMP-dependent and independent signal transduction mechanisms. Mol. Cell. Biochem. 141, 103-111. doi: 10.1007/BF00926173
134. Pandey, K. N. (1994b). Atrial natriuretic factor inhibits the phosphorylation of protein kinase C in plasma membrane preparations of cultured Leydig tumor cells. J. Androl. 15, 100-109. doi: 10.1007/BF00926173
135. Pandey, K. N. (2001). Dynamics of internalization and sequestration of guanylyl cyclase/atrial natriuretic peptide receptor-A. Can. J. Physiol. Pharmacol. 79, 631-639. doi: 10.1139/y01-035
136. Pandey, K. N. (2002). Intracellular trafficking and metabolic turnover of ligand-bound guanylyl cyclase/atrial natriuretic peptide receptor-A into subcellular compartments. Mol. Cell. Biochem. 230, 61-72. doi: 10.1023/A:1014240006767
137. Pandey, K. N. (2005). Biology of natriuretic peptides and their receptors. Peptides 26, 901-932. doi: 10.1016/j.peptides.2004.09.024
138. Pandey, K. N. (2011). The functional genomics of guanylyl cyclase/natriuretic peptide receptor-A: perspectives and paradigms. FEBS J. 278, 1792-1807. doi: 10.1111/j.1742-4658.2011.08081.x
139. Pandey, K. N., Inagami, T., and Misono, K. S. (1986). Atrial natriuretic factor receptor on cultured Leydig tumor cells: ligand binding and photoaffinity labeling. Biochemistry 25, 8467-8472. doi: 10.1021/bi00374a022
140. Pandey, K. N., Kovacs, W. J., and Inagami, T. (1985). The inhibition of progesterone secretion and the regulation of cyclic nucleotides by atrial natriuretic factor in gonadotropin responsive murine Leydig tumor cells. Biochem. Biophys. Res. Commun. 133, 800-806. doi: 10.1016/0006-291X(85)90975-1
141. Pandey, K. N., Nguyen, H. T., Sharma, G. D., Shi, S. J., and Kriegel, A. M. (2002). Ligand-regulated internalization, trafficking, and down-regulation of guanylyl cyclase/atrial natriuretic peptide receptor-A in human embryonic kidney 293 cells. J. Biol. Chem. 277, 4618-4627. doi: 10.1074/jbc.M106436200
142. Pandey, K. N., Oliver, P. M., Maeda, N., and Smithies, O. (1999). Hypertension associated with decreased testosterone levels in natriuretic peptide receptor-A gene-knockout and gene-duplicated mutant mouse models. Endocrinology 140, 5112-5119.
143. Pandey, K. N., Pavlou, S. N., and Inagami, T. (1988). Identification and characterization of three distinct atrial natriuretic factor receptors. Evidence for tissue-specific heterogeneity of receptor subtypes in vascular smooth muscle, kidney tubular epithelium, and Leydig tumor cells by ligand binding, photoaffinity labeling, and tryptic proteolysis. J. Biol. Chem. 263, 13406-13413.
144. Pandey, K. N., and Singh, S. (1990). Molecular cloning and expression of murine guanylate cyclase/atrial natriuretic factor receptor cDNA. J. Biol. Chem. 265, 12342-12348.
145. Paul, A. K., Marala, R. B., Jaiswal, R. K., and Sharma, R. K. (1987). Coexistence of guanylate cyclase and atrial natriuretic factor receptor in a 180-kD protein. Science 235, 1224-1226. doi: 10.1126/science.2881352
146. Phillips, R. A., Ardeljan, M., Shimabukuro, S., Goldman, M. E., Garbowit, D. L., Eison, H. B., et al. (1991). Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after 1 year of sustained nifedipine therapy for severe hypertension. J. Am. Coll. Cardiol. 17, 1595-1602. doi: 10.1016/0735-1097(91)90654-R
147. Pollman, M. J., Yamada, T., Horiuchi, M., and Gibbons, G. H. (1996). Vasoactive substances regulate vascular smooth muscle cell apoptosis. Circ. Res. 79 748-756. doi: 10.1161/01.RES.79.4.748
148. Potter, L. R., and Garbers, D. L. (1992). Dephosphorylation of the guanylyl cyclase-A receptor causes desensitization. J. Biol. Chem. 267, 14531-14534.
149. Prins, B. A., Weber, M. J., Hu, R.-M., Pedram, A., Daniels, M., and Levin, E. R. (1996). Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor Potential role in the inhibition of astrocyte proliferation. J. Biol. Chem. 271, 14156-14162. doi: 10.1074/jbc.271.24.14156
150. Rashatwar, S. S., Cornwell, T. L., and Lincoln, T. M. (1987). Effect of 8-bromo cGMP on Ca2+-ATPase by cGMP dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A 84, 5685-5689. doi: 10.1073/pnas.84.16.5685
151. Rasmussen, H., Isales, C. M., Calle, R. A., Throckmorton, D., Anderson, M., Gasalla-Harraiz, J., et al. (1995). Diacylglycerol production, Ca2+ influx and protein kinase c activation in sustained cellular responses. Endocr. Rev. 16, 649-681.
152. Rathinavelu, A., and Isom, G. E. (1991). Differential internalization and precessing of atrial natriuretic factor B and C receptors in PC-12 cells. Biochem. J. 276, 493-497.
153. Resink, T. J., Scott-Burden, T., Baur, U., Jones, C. R., and Buhler, F. R. (1988). Atrial natriuretic peptide induces breakdown of phosphatidylinositol phosphates in cultured vascular smooth muscle cells. Eur. J. Biochem. 172, 499-505. doi: 10.1111/j.1432-1033.1988.tb13915.x
154. Rogers, J., Hughes, R. J., and Mathes, E. K. (1988). cGMP inhibits protein kinase C-mediated secretion in rat pancreatic acini. J. Biol. Chem. 263, 3713-3719.
155. Rosenzweig, A., and Seidman, C. E. (1991). Atrial natriuretic factor and related peptide hormones. Annu. Rev. Biochem. 60, 229-255. doi: 10.1146/annurev.bi.60.070191.001305
156. Sano, T., Morishita, Y., Matsuda, Y., and Yamada, K. (1992). Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats. J. Pharmacol. Exp. Ther. 260, 825-831.
157. Sauro, M. D., and Fitzpatrick, D. F. (1990). Atrial natriuretic peptides inhibit protien kinase C activation in rat aortic smooth muscle. Pept. Res. 3, 138-141.
158. Saxenhofer, H., Raselli, A., Weidmann, P., Forssmann, W. G., Bub, A., Ferrari, P., et al. (1990). Urodilatin, a natriuretic factor from kidneys, can modify renal and cardiovascular function in men. Am. J. Physiol. 259, F832-F838.
159. Schenk, D. B., Phelps, M. N., Porter, J. G., Scarborough, R. M., Mcenroe, G. A., and Lewicki, J. A. (1985). Identification of the receptor for atrial natriuretic factor on cultured vascular cells. J. Biol. Chem. 260, 14887-14890.
160. Schulz-Knappe, P., Forssmann, K., Herbst, F., Hock, D., Pipkorn, R., and Forssmann, W. G. (1988). Isolation and structural analysis of "urodilatin", a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin. Wochenschr. 66, 752-759. doi: 10.1007/BF01726570
161. Schulz, S., Singh, S., Bellet, R. A., Singh, G., Tubb, D. J., Chin, H., et al. (1989). The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family. Cell 58, 1155-1162. doi: 10.1016/0092-8674(89)90513-8
162. Schweitz, H., Vigne, P., Moinier, D., Frelin, C., and Lazdunski, M. (1992). A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps). J. Biol. Chem. 267, 13928-13932.
163. Sharma, G. D., Nguyen, H. T., Antonov, A. S., Gerrity, R. G., Von Geldern, T., and Pandey, K. N. (2002). Expression of atrial natriuretic peptide receptor-A antagonizes the mitogen-activated protein kinases (Erk2 and P38MAPK) in cultured human vascular smooth muscle cells. Mol. Cell. Biochem. 233, 165-173. doi: 10.1023/A:1015882302796
164. Sharma, R. K. (2002). Evolution of the membrane guanylate cyclase transduction system. Mol. Cell. Biochem. 230, 3-30. doi: 10.1023/A:1014280410459
165. Sharma, R. K., and Duda, T. (2010). ROS-GC subfamily membrane guanylate cyclase-linked transduction systems: taste, pineal gland and hippocampus. Mol. Cell. Biochem. 334, 199-206. doi: 10.1007/s11010-009-0334-8
166. Shi, S. J., Nguyen, H. T., Sharma, G. D., Navar, L. G., and Pandey, K. N. (2001). Genetic disruption of atrial natriuretic peptide receptor-A alters renin and angiotensin II levels. Am. J. Physiol. 281, F665-F673.
167. Shi, S. J., Vellaichamy, E., Chin, S. Y., Smithies, O., Navar, L. G., and Pandey, K. N. (2003). Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion. Am. J. Physiol. 285, F694-F702.
168. Sibley, D. R., Benovic, J. L., Caron, M. G., and Lefkowitz, R. J. (1987). Regulation of transmembrane signaling by receptor phosphorylation. Cell 48, 913-933. doi: 10.1016/0092-8674(87)90700-8
169. Silberbach, M., Gorenc, T., Hershberger, R. E., Stork, P. J. S., Steyger, P. S., and Roberts, C. T. J. (1999). Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes. J. Biol. Chem. 274, 24858-24864. doi: 10.1074/jbc.274.35.24858
170. Sorkin, A., and von Zastrow, M. (2002). Signal transduction and endocytosis close encounters of many kinds. Nat. Rev. Mol. Cell Biol. 3, 600-614. doi: 10.1038/nrm883
171. Sudoh, T., Minamino, N., Kangawa, K., and Matsuo, H. (1988). Brain natriuretic peptide-32: N-terminal six amino acid extended form of brain natriuretic peptide identified in porcine brain. Biochem. Biophys. Res. Commun. 155, 726-732. doi: 10.1016/S0006-291X(88)80555-2
172. Sudoh, T., Minamino, N., Kangawa, K., and Matsuo, H. (1990). C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun. 168, 863-870. doi: 10.1016/0006-291X(90)92401-K
173. Suga, S., Itoh, H., Komatsu, Y., Ogawa, Y., Hama, N., Yoshimasa, T., et al. (1993). Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells-evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology 133, 3038-3041.
174. Suga, S., Nakao, K., Itoh, H., Komatsu, Y., Ogawa, Y., Hama, N., et al. (1992). Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system. " J. Clin. Invest. 90, 1145-1149. doi: 10.1172/JCI115933
175. Sugimoto, T., Kikkawa, R., Haneda, M., and Shigeta, Y. (1993). Atrial natriuretic peptide inhibits endothelin-1 induced activation of mitogen-activated protein kinase in cultured rat mesangial cells. Biochem. Biophys. Res. Commun. 195, 72-78. doi: 10.1006/bbrc.1993.2011
176. Takahashi, N., and Smithies, O. (1999). Gene targeting approaches to analyzing hypertension. J. Am. Soc. Nephrol. 10, 1598-1605.
177. Takayanagi, R., Snajdar, R. M., Imada, T., Tamura, M., Pandey, K. N., Misono, K. S., et al. (1987). Purification and characterization of two types of atrial natriuretic factor receptors from bovine adrenal cortex: guanylate cyclase-linked and cyclase-free receptors. Biochem. Biophys. Res. Commun. 144, 244-250. doi: 10.1016/S0006-291X(87)80502-8
178. Tamura, N., Ogawa, Y., Yasoda, A., Itoh, H., Saito, Y., and Nakao, K. (1996). Two cardiac natriuretic peptide genes (atrial natriuretic peptide and brain natriuretic peptide) are organized in tandem in the mouse and human genomes. J. Mol. Cell Cardiol. 28, 1811-1815. doi: 10.1006/jmcc.1996.0170
179. Teitelbaum, I., Strasheim, A., and Berl, T. (1990). Epidermal growth factor-stimulated phosphonositide hydrolysis in cultured rat inner medullary collecting tubule cells. Regulation by G protein, calcium, and protein kinase C. J. Clin. Invest. 85, 1044-1050. doi: 10.1172/JCI114534
180. Thomas, P., and Meizel, S. (1989). Phosphatidylinositol 4, 5-bisphosphate hydrolysis in human sperm stimulated with follicular fluid or progesterone is dependent upon Ca2+ influx. Biochem. J. 264, 539-546.
181. Trindade, P., Hutchinson, H. G., Pollman, M. J., Gibbons, G. H., and Pratt, R. E. (1995). Atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP) induce apoptosis in vascular smooth muscle cells (VMSC). Circulation92, 1-696.
182. Tripathi, S., and Pandey, K. N. (2012). Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes the vascular endothelial growth factor-stimulated MAPKs and downstream effectors AP-1 and CREB in mouse mesangial cells. Mol. Cell. Biochem. 368, 47-59. doi: 10.1007/s11010-012-1341-8
183. Turla, M. B., Park, S. M., and Webb, R. C. (1990). Vascular responsiveness to phorbol esters in coarctation-hypertensive rats. J. Hypertens. 8, 191-196. doi: 10.1097/00004872-199002000-00015
184. Turovsky, E. A., Turovskaya, M. V., Dolgacheva, L. P., Zinchenko, V. P., and Dynnik, V. V. (2013). Acetylcholine promotes Ca2+ and NO-oscillations in adipocytes implicating Ca2+-> NO-> cGMP-> cADP-ribose-> Ca2+ positive feedback loop-modulatory effects of norepinephrine and atrial natriuretic peptide. PLoS ONE 8: e63483. doi: 10.1371/journal.pone.0063483
185. van den Akker, F. (2001). Structural insights into the ligand binding domains of membrane bound guanylyl cyclases and natriuretic peptide receptors. J. Mol. Biol. 311, 923-937. doi: 10.1006/jmbi.2001.4922
186. van den Akker, F., Zhang, X., Miyagi, M., Huo, X., Misono, K. S., and Yee, V. C. (2000). Structure of the dimerized hormone-binding domain of a guanylyl-cyclase-coupled receptor. Nature 406, 101-104. doi: 10.1038/35017602
187. Vandlen, R. L., Arcuri, K. E., and Napier, M. A. (1985). Identification of a receptor for atrial natriuretic factor in rabbit aorta membranes by affinity cross-linking. J. Biol. Chem. 260, 10889-10892.
188. Vellaichamy, E., Das, S., Subramanian, U., Maeda, N., and Pandey, K. N. (2014). Genetically altered mutant mouse models of guanylyl cyclase/natriuretic peptide receptor-A exhibit the cardiac expression of proinflammatory mediators in a gene-dose-dependent manner. Endocrinology 155, 1045-1056. doi: 10.1210/en.2013-1416
189. Vellaichamy, E., Khurana, M. L., Fink, J., and Pandey, K. N. (2005). Involvement of the NF-kappa B/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase/natriuretic peptide receptor A. J. Biol. Chem. 280, 19230-19242. doi: 10.1074/jbc.M411373200
190. Vellaichamy, E., Zhao, D., Somanna, N., and Pandey, K. N. (2007). Genetic disruption of guanylyl cyclase/natriuretic peptide receptor-A upregulates ACE and AT1 receptor gene expression and signaling: role in cardiac hypertrophy. Physiol. Genomics 31, 193-202. doi: 10.1152/physiolgenomics.00079.2007
191. von Geldern, T. W., Budzik, G. P., Dillon, T. P., Holleman, W. H., Holst, M. A., Ksio, Y., et al. (1990). Atrial natriuretic peptide antagonists biological evaluation and structural correlations. Mol. Pharmacol. 38, 771-778.
192. Waldman, S. A., Rapoport, R. M., and Murad, F. (1984). Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues. J. Biol. Chem. 259, 14332-14334.
193. White, R. E., Lee, A. B., Shcherbatko, A. D., Lincoln, T. M., Schonbrunn, A., and Armstrong, D. L. (1993). Potassium channel stimulation by natriuretic peptides through cGMP-dependent dephosphorylation. Nature 361, 263-266. doi: 10.1038/361263a0
194. Wilson, E. M., and Chinkers, M. (1995). Identification of sequences mediating guanylyl cyclase dimerization. Biochemistry 34, 4696-4701. doi: 10.1021/bi00014a025
195. Wong, S. K., Ma, C. P., Foster, D. C., Chen, A. Y., and Garbers, D. L. (1995). The guanylyl cyclase-A receptor transduces an atrial natriuretic peptide/ATP activation signal in the absence of other proteins. J. Biol. Chem. 270, 30818-30822. doi: 10.1074/jbc.270.51.30818
196. Wormald, M. R., and Dwek, R. A. (1999). Glycoproteins glycan presentation and protein-fold stability. Structure 7, R155-R160. doi: 10.1016/S0969-2126(99)80095-1
197. Wu, C. F., Bishopric, N. H., and Pratt, R. E. (1997). Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J. Biol. Chem. 272, 14860-14866. doi: 10.1074/jbc.272.23.14860
198. Yoshihara, F., Tokudome, T., Kishimoto, I., Otani, K., Kuwabara, A., Horio, T., et al. (2014). Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides. Clin. Exp. Nephrol. doi: 10.1007/s10157-014-0982-1[Epubaheadofprint].
199. Yoshimura, M., Yasue, H., Morita, E., Sakaino, N., Jougasaki, M., Kurose, M., et al. (1991). Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 84, 1581-1588. doi: 10.1161/01.CIR.84.4.1581
200. Yoshimura, M., Yasue, H., Okumura, K., Ogawa, H., Jougasaki, M., Mukoyama, M., et al. (1993). Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 87, 464-469. doi: 10.1161/01.CIR.87.2.464
201. Zhao, D., Das, S., and Pandey, K. N. (2013). Interactive roles of NPR1 gene-dosage and salt diets on cardiac angiotensin II, aldosterone and pro-inflammatory cytokines levels in mutant mice. J. Hypertens. 31, 134-144. doi: 10.1097/HJH.0b013e32835ac15f
202. Zhao, D., Vellaichamy, E., Somanna, N. K., and Pandey, K. N. (2007). Guanylyl cyclase/natriuretic peptide receptor-A gene disruption causes increased adrenal angiotensin II and aldosterone levels. Am. J. Physiol. 293, F121-F127. doi: 10.1152/ajprenal.00478.2006
203. Zhao, L., Long, L., and Morrell, N. W. (1999). NPRA-deficient mice show increased susceptibility to hypoxia-induced pulmonary hypertension. Circulation 99, 605-607. doi: 10.1161/01.CIR.99.5.605
204. Zhou, H., and Murthy, K. S. (2003). Identification of the G-protein activation sequence of the single-transmembrane natriuretic peptide receptor C (NPR-C). Am. J. Cell. Physiol. 284, C1255-C1261. doi: 10.1152/ajpcell.00520.2002
205. Zolle, O., Lawrie, A. M., and Simpson, A. W. (2000). Activation of the particulate and not the soluble guanylate cyclase leads to the inhibition of Ca2+ extrusion through localized elevation of cGMP. J. Biol. Chem. 275, 25892-25899. doi: 10.1074/jbc.M000786200